APPLIED THERAPEUTICS, INC.

Insiders Applied Therapeutics, Inc.

Equities

APLT

US03828A1016

Real-time Estimate Cboe BZX Other stock markets 11:24:33 2024-06-11 am EDT			5-day change	1st Jan Change
5.25 ^USD	+2.74%		+24.15%	+56.39%

May. 09	Applied Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 09	Earnings Flash (APLT) APPLIED THERAPEUTICS Posts Q1 Revenue $190,000	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Applied Therapeutics, Inc. Announces Management Changes	Apr. 15	CI
Waning Rate Cut Hopes, Employment Situation Report Push Down Exchange-Traded Funds, Equity Futures Pre-Bell Friday	Jan. 05	MT
Applied Therapeutics, Inc. Appoints Constantine Chinoporos as the Company?s Chief Operating Officer and Chief Business Officer	Dec. 29	CI
Applied Therapeutics, Inc. Appoints Les Funtleyder as Chief Financial Officer, Effective November 20, 2023	Nov. 17	CI
Applied Therapeutics Insider Sold Shares Worth $312,206, According to a Recent SEC Filing	23-10-02	MT
Applied Therapeutics, Inc. Announces Executive Changes	23-06-16	CI
Applied Therapeutics, Inc. Announces Executive Changes	23-02-24	CI
Applied Therapeutics, Inc. Appoints Charles Silberstein as Head of Business Development	20-05-26	CI
Applied Therapeutics, Inc. Appoints Chids Mahadevan as Principal Accounting Officer	20-04-01	CI
Applied Therapeutics Appoints Adam Hansard as Chief Commercial Officer	20-03-03	CI
Applied Therapeutics, Inc. Appoints Mark Vignola as Chief Financial Officer	19-04-29	CI
Applied Therapeutics, Inc. Announces Management Appointments	18-09-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer